Since PLCXD3, CCL19, and PKD2 might be pivotal in the progression of advanced AS (GES28829) and NAFLD (GSE49541), we selected these genes separately for further single-gene GSEA to confirm the findings of GSVA. This evidence concerns the gene PLCXD3 and metabolic dysfunction-associated steatotic liver disease.